STOCK TITAN

Pyrophyte Acquisition II (PAII) 8-K Filings

PAII NYSE

Here are the 8-K filings from Pyrophyte Acquisition Corp. II (PAII) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An 8-K covers material events a company has to report between its quarterly reports, so if you follow PAII and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAII filings page.

Rhea-AI Summary

Pyrophyte Acquisition Corp. II (PAII) entered into a proposed business combination agreement with Sakuu Corporation and Pyrophyte Merger Sub, Inc. Sakuu equityholders would receive 60,000,000 newly issued New Pyrophyte common shares, calculated by dividing $600,000,000 by $10.00 per share. Pyrophyte would domesticate in Delaware, change its name to Sakuu Holdings, Inc., and merge the subsidiary into Sakuu, which would survive as a wholly owned subsidiary.

Closing is subject to shareholder approvals, an effective Form S-4, antitrust waiting-period expiration, listing approval and other conditions; Sakuu's obligations also require at least $30,000,000 of Net Closing Cash. IPO Class A holders would have a redemption opportunity immediately before closing. Either party may terminate if the combination is not completed by May 31, 2027.

During the five-year earnout period, closing sale-price tests of at least $12.50 and $15.00—each requiring 20 Trading Days within any 30 consecutive Trading Day period—would trigger reserves of 5,000,000 shares per threshold for eligible current employees, directors and individual service providers. The sponsor agreed to vote its shares for the combination and waive specified anti-dilution rights.